Kathleen E. Wiley

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Igor Puzanov, Adi Diab, K. Abdallah et al. · Journal for ImmunoTherapy of Cancer · 2017 · 2K citations · Full text

Life Sciences, Immunology, Oncology +17

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24

Patrick Sulem, Andrei Manolescu, Laufey T. Ámundadóttir et al. · Nature Genetics · 2007 · 867 citations

Life Sciences, Genetics, Molecular Genetics +11

Germline Mutations in <i>HOXB13</i> and Prostate-Cancer Risk

Charles M. Ewing, Anna M. Ray, Ethan M. Lange et al. · New England Journal of Medicine · 2012 · 670 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

John D. Carpten, Nina N. Nupponen, Sarah D. Isaacs et al. · Nature Genetics · 2002 · 527 citations

Life Sciences, Genetics, Molecular Genetics +8

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

Jianfeng Xu, Shusen Zheng, Akira Komiya et al. · Nature Genetics · 2002 · 389 citations

Medicine, Genetics, Molecular Genetics +17